Millipore to Sell $550M in New Notes to Help Fund Serologicals Acquisition

Millipore said this week that it plans to raise $550 million in convertible senior notes to finance its acquisition of Serologicals.

The notes, due 2026, will be offered to institutional buyers.

Millipore said in April that it would acquire Serologicals for $1.4 billion in cash. Millipore said it will use a portion of its latest fundraising round to pay for a portion of the acquisition.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.